AMAG Pharmaceuticals to Present at Upcoming Investor Conferences
May 25 2016 - 8:00AM
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that
company management will discuss AMAG’s business and financial
outlook, strategy and growth prospects at the following investor
conferences taking place in June 2016.
- Jefferies 2016 Healthcare
ConferencePresentation: Tuesday, June 7, 2016
at 10:00 a.m. ET*One-on-one meetings: Tuesday, June 7,
2016Location: New York, NY
- Barclays High Yield Bond & Syndicated Loan
ConferencePresentation: Thursday, June 9, 2016
at 5:25 p.m. ET*One-on-one meetings: Thursday, June 9,
2016Location: Colorado Springs, CO
*A live webcast of the presentation will be accessible through
the Investors section of the company’s website
at www.amagpharma.com, and will be archived for 30
days.
About AMAGAMAG is a
biopharmaceutical company focused on bringing therapeutics to
market that provide clear benefits and help improve people’s lives.
Headquartered in Waltham, MA, AMAG possesses a diverse portfolio of
products to support the health of patients in the areas of maternal
health, anemia management and cancer supportive care. Through CBR®,
the company also helps families to preserve newborn stem cells,
which are used today in transplant medicine for certain cancers and
blood, immune and metabolic disorders, and have the potential to
play a valuable role in the ongoing development of regenerative
medicine. For additional company information, please visit
www.amagpharma.com.
AMAG Pharmaceuticals® is a registered trademark of AMAG
Pharmaceuticals, Inc. and CBR® is a registered trademark
of CBR Systems, Inc.
AMAG Pharmaceuticals Contact:
Maryann Cimino
Manager, Corporate Communications & External Affairs
617-498-3375
AMAG Pharmaceuticals (NASDAQ:AMAG)
Historical Stock Chart
From Mar 2024 to Apr 2024
AMAG Pharmaceuticals (NASDAQ:AMAG)
Historical Stock Chart
From Apr 2023 to Apr 2024